IMMUNO-STAT Trademark

Trademark Overview

On Wednesday, September 25, 2019, a trademark application was filed for IMMUNO-STAT with the United States Patent and Trademark Office. The USPTO has given the IMMUNO-STAT trademark a serial number of 88630491. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 19, 2023. This trademark is owned by CUE BIOPHARMA, INC.. The IMMUNO-STAT trademark is filed in the Pharmaceutical Products category with the following description:

Biopharmaceutical preparations for treating cancer, autoimmune diseases and infectious diseases; immunotherapeutic preparations for treating cancer, autoimmune diseases and infectious diseases
immuno-stat

General Information

Serial Number88630491
Word MarkIMMUNO-STAT
Filing DateWednesday, September 25, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 24, 2020

Trademark Statements

Goods and ServicesBiopharmaceutical preparations for treating cancer, autoimmune diseases and infectious diseases; immunotherapeutic preparations for treating cancer, autoimmune diseases and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCUE BIOPHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02135
Party NameCUE BIOPHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, June 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 19, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 23, 2022SOU EXTENSION 5 GRANTED
Monday, November 14, 2022SOU EXTENSION 5 FILED
Wednesday, November 23, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 14, 2022SOU TEAS EXTENSION RECEIVED
Saturday, May 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 19, 2022SOU EXTENSION 4 GRANTED
Thursday, May 19, 2022SOU EXTENSION 4 FILED
Thursday, May 19, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 19, 2021SOU EXTENSION 3 GRANTED
Friday, November 19, 2021SOU EXTENSION 3 FILED
Friday, November 19, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 17, 2021SOU EXTENSION 2 GRANTED
Monday, May 17, 2021SOU EXTENSION 2 FILED
Monday, May 17, 2021SOU TEAS EXTENSION RECEIVED
Friday, November 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 18, 2020SOU EXTENSION 1 GRANTED
Wednesday, November 18, 2020SOU EXTENSION 1 FILED
Wednesday, November 18, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, May 19, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 24, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 18, 2020ASSIGNED TO LIE
Monday, February 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 28, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, December 28, 2019NON-FINAL ACTION E-MAILED
Saturday, December 28, 2019NON-FINAL ACTION WRITTEN
Saturday, December 28, 2019ASSIGNED TO EXAMINER
Tuesday, October 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 28, 2019NEW APPLICATION ENTERED

Related Keywords

stat immuno diseases infectious autoimmune cancer preparations treating immunotherapeutic biopharmaceutical